Novo Nordisk’s Wegovy will be competing with Madrigal Pharmaceuticals’ Rezdiffra in the metabolic dysfunction-associated ...

Nobuyuki Ishibashi, MD, professor of anatomy & neurobiology at Boston University Chobanian & Avedisian School of Medicine, has been awarded a four-year, $6.5 M grant from the Department of Defense’s ...

ZyVersa Therapeutics (ZVSA) highlights data from a peer-reviewed article, The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its ...

The published data provide evidence that inflammasome-induced inflammation plays a central role in the development and progression of T2DM and its cardiovascular complications by promoting insulin ...

Findings showed the trial met the primary endpoint, with enlicitide demonstrating a statistically significantly meaningful reduction in LDL-C compared with placebo. Topline data were announced from a ...

NEW YORK – Ideaya Biosciences on Wednesday said it submitted an investigational new drug application to the US Food and Drug Administration seeking permission to test its PRMT5 inhibitor IDE892 in ...

The FDA approved oral rilzabrutinib (Wayrilz) for treating persistent or chronic immune thrombocytopenia (ITP), the agency announced on Tuesday. As the first Bruton's tyrosine kinase (BTK) inhibitor ...

Human endogenous retroviruses (HERVs) were domesticated millions of years ago as ancestral relics through germline infections and have become part of the human genome (8.3%). Over time, HERVs lost ...

Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University, China. (Q.D., X.Z., L.F., A.C., Z.L., Y.Y., J.Z ...

State Key Laboratory of Chemical Biology, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 200032, China State Key Laboratory of Chemical Biology, Shanghai Institute of ...

After throwing down $70 million upfront to partner on Black Diamond Therapeutics’ solid tumor candidate earlier this year, Servier is pulling out its checkbook to ink yet another oncology licensing ...

Lassogen, Inc., 3830 Valley Centre Drive, Suite 705-562, San Diego, California 92130, United States ...